Patents by Inventor Zdenka Haskova

Zdenka Haskova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MACHINE LEARNING PREDICTION OF INJECTION FREQUENCY IN PATIENTS WITH MACULAR EDEMA
    Publication number: 20230317288
    Abstract: A method and system for managing a treatment of a subject diagnosed with a macular edema condition. Subject data for a subject is received. The subject data comprises best corrected visual acuity (BCVA) data for the subject. An input for a computational model is generated using the subject data. An injection frequency for the treatment of the subject diagnosed with the macular edema condition is predicted, via the computational model, based on the input.
    Type: Application
    Filed: March 22, 2023
    Publication date: October 5, 2023
    Inventors: Yvonna Yun LI, Verena Lisa STEFFEN, Fethallah BENMANSOUR, Michel James FRIESENHAHN, Zdenka HASKOVA
  • Antigen binding proteins
    Patent number: 9085622
    Abstract: The present disclosure relates to antigen binding proteins, such as antibodies, that bind to HER3, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present disclosure also concerns the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic, gastric, melanoma and other cancers that overexpress HER3.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: July 21, 2015
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Neil James Clarke, Kyung Oh Johanson, Zdenka Ludmila Jonak, Alexander H. Taylor, Christopher B. Hopson, Stephen H. Trulli, Zdenka Haskova, Judithann M. Lee, John R. White, Yu Xue
  • NOVEL ANTIGEN BINDING PROTEINS
    Publication number: 20130156779
    Abstract: The present disclosure relates to antigen binding proteins, such as antibodies, that bind to HER3, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present disclosure also concerns the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic, gastric, melanoma and other cancers that overexpress HER3.
    Type: Application
    Filed: September 2, 2011
    Publication date: June 20, 2013
    Inventors: Neil James Clarke, Kyung Oh Johanson, Zdenka Ludmila Jonak, Alexander H. Taylor, Christopher B. Hopson, Stephen H. Trulli, Zdenka Haskova, Judithann M. Lee, John R. White, Yu Xue
  • METHODS OF TREATING CANCER BY ADMINISTERING HUMAN IL-18 COMBINATIONS
    Publication number: 20100196310
    Abstract: The present invention relates generally to the use of human IL-18 combinations in the treatment of various forms of solid tumors and lymphomas. In particular, the present invention relates to: (1) combinations of human IL-18 with monoclonal antibodies against antigens that are expressed on the surface of cancer cells; and (2) combinations of human IL-18 with chemotherapeutic agents.
    Type: Application
    Filed: March 20, 2008
    Publication date: August 5, 2010
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Zdenka Haskova, Zdenka Ludmila Jonak, Stephen H. Trulli, Margaret N. Whitacre
  • NOVEL USES
    Publication number: 20100111945
    Abstract: The present invention relates generally to the use of human IL-18 combinations in the treatment of cancers. In particular, the present invention relates to combination of human IL-18 and an anti-CD20 antibody.
    Type: Application
    Filed: March 20, 2008
    Publication date: May 6, 2010
    Inventors: Zdenka Haskova, Zdenka Ludmila Jonak, Stephen H. Trulli, John F. Toso, Margaret N. Whitacre
  • METHODS OF TREATING CANCER BY ADMINISTERING HUMAN IL-18 COMBINATIONS
    Publication number: 20090035258
    Abstract: The present invention relates generally to the use of human IL-18 combinations in the treatment of various forms of solid tumors and lymphomas. In particular, the present invention relates to: (1) combinations of human IL-18 with monoclonal antibodies against antigens that are expressed on the surface of cancer cells; and (2) combinations of human IL-18 with chemotherapeutic agents.
    Type: Application
    Filed: March 20, 2008
    Publication date: February 5, 2009
    Inventors: Zdenka Haskova, Zdenka Ludmila Jonak, Stephen H. Trulli, Margaret N. Whitacre
  • NOVEL USES
    Publication number: 20080274078
    Abstract: The present invention relates generally to the use of human IL-18 combinations in the treatment of cancers. In particular, the present invention relates to combination of human IL-18 and an anti-CD20 antibody.
    Type: Application
    Filed: March 20, 2008
    Publication date: November 6, 2008
    Inventors: Zdenka HASKOVA, Zdenka Ludmila JONAK, Stephen H. TRULLI, John F. TOSO, Margaret N. WHITACRE